Bactiguard Holding Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Public

  • Employees
  • 156

Employees

  • Stock Symbol
  • BACTI B

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $1.46
  • (As of Thursday Closing)

Bactiguard Holding General Information

Description

Bactiguard Holding AB is a medical device company. It is engaged in a MedTech company developing safe and biocompatible technology to prevent medical device-related infections. The technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. The company focuses on five strategic therapeutic areas wherein infection rates create high medical needs for infection prevention. These areas include Orthopedics, Cardiology, Neurology, Urology, and Vascular Access. Geographically, the company operates in the USA, Malaysia, China, Saudi Arabia, Bangladesh, Sweden, the Czech Republic, and Other countries. The majority of its revenue is generated from the USA region.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Vasagatan 11
  • 111 20 Stockholm
  • Sweden
+46 08-440
Primary Industry
Other Healthcare Services
Other Industries
Medical Supplies
Therapeutic Devices
Stock Exchange
STO
Corporate Office
  • Vasagatan 11
  • 111 20 Stockholm
  • Sweden
+46 08-440

Bactiguard Holding Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bactiguard Holding Stock Performance

As of 12-Nov-2026, Bactiguard Holding’s stock price is $1.46. Its current market cap is $51.2M with 35M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.46 $1.56 $1.43 - $2.33 $51.2M 35M 7.1K $0.02

Bactiguard Holding Financials Summary

As of 30-Sep-2026, Bactiguard Holding has a trailing 12-month revenue of $22.9M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 66,401 89,928 124,112 227,863
Revenue 22,852 21,977 22,852 19,192
EBITDA 5,213 4,129 2,046 (8,491)
Net Income 640 (798) (2,819) (13,019)
Total Assets 52,444 59,234 59,447 66,258
Total Debt 15,381 17,705 20,643 23,324
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bactiguard Holding Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bactiguard Holding‘s full profile, request access.

Request a free trial

Bactiguard Holding Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Bactiguard Holding AB is a medical device company. It is engaged in a MedTech company developing safe and biocompatible
Other Healthcare Services
Stockholm, Sweden
156 As of 2026

Franklin Lakes, NJ
 

London, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bactiguard Holding Competitors (15)

One of Bactiguard Holding’s 15 competitors is Becton, Dickinson and Company, a Corporation company based in Franklin Lakes, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Becton, Dickinson and Company Corporation Franklin Lakes, NJ
LivaNova Formerly VC-backed London, United Kingdom
Medtronic Corporation Minneapolis, MN
Endologix Corporation Santa Rosa, CA
Globus Medical Formerly VC-backed Audubon, PA
You’re viewing 5 of 15 competitors. Get the full list »

Bactiguard Holding Patents

Bactiguard Holding Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4770692-A1 Silver free surface coating with palladium and gold Pending 12-Sep-2024
WO-2026057638-A1 Silver free surface coating with palladium and gold Pending 12-Sep-2024
AU-2024209121-A1 An antimicrobial gel composition Pending 20-Jan-2023
EP-4651719-A1 An antimicrobial gel composition Pending 20-Jan-2023
US-20260216235-A1 An antimicrobial gel composition Pending 20-Jan-2023 A61K33/00
To view Bactiguard Holding’s complete patent history, request access »

Bactiguard Holding Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bactiguard Holding Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bactiguard Holding‘s full profile, request access.

Request a free trial

Bactiguard Holding Investments & Acquisitions (2)

Bactiguard Holding’s most recent deal was a Early Stage VC with Teint for . The deal was made on 18-Apr-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Teint 18-Apr-2023 Early Stage VC Personal Products
Vigilenz Medical Devices 28-Feb-2020 Merger/Acquisition Medical Supplies
To view Bactiguard Holding’s complete investments and acquisitions history, request access »

Bactiguard Holding ESG

Risk Overview

Risk Rating

Updated October, 31, 2024

24.13 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,999

Rank

Percentile

Healthcare

Industry

of 665

Rank

Percentile

Medical Supplies

Subindustry

of 65

Rank

Percentile

To view Bactiguard Holding’s complete esg history, request access »

Bactiguard Holding FAQs

  • When was Bactiguard Holding founded?

    Bactiguard Holding was founded in 2005.

  • Where is Bactiguard Holding headquartered?

    Bactiguard Holding is headquartered in Stockholm, Sweden.

  • What is the size of Bactiguard Holding?

    Bactiguard Holding has 156 total employees.

  • What industry is Bactiguard Holding in?

    Bactiguard Holding’s primary industry is Other Healthcare Services.

  • Is Bactiguard Holding a private or public company?

    Bactiguard Holding is a Public company.

  • What is Bactiguard Holding’s stock symbol?

    The ticker symbol for Bactiguard Holding is BACTI B.

  • What is the current stock price of Bactiguard Holding?

    As of 12-Nov-2026 the stock price of Bactiguard Holding is $1.46.

  • What is the current market cap of Bactiguard Holding?

    The current market capitalization of Bactiguard Holding is $51.2M.

  • What is Bactiguard Holding’s current revenue?

    The trailing twelve month revenue for Bactiguard Holding is $22.9M.

  • Who are Bactiguard Holding’s competitors?

    Becton, Dickinson and Company, LivaNova, Medtronic, Endologix, and Globus Medical are some of the 15 competitors of Bactiguard Holding.

  • What is Bactiguard Holding’s annual earnings per share (EPS)?

    Bactiguard Holding’s EPS for 12 months was $0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process